海尔生物：注销145.96万股回购股份，总股本减少

Core Viewpoint - Haier Bio has completed a partial share repurchase and cancellation, which is aimed at fulfilling commitments and enhancing investor returns, with no significant impact on the company's operations [1] Group 1: Share Repurchase and Cancellation - The company has canceled 1,459,586 shares, representing 0.46% of the total share capital before cancellation, which was 317,952,508 shares [1] - Following the cancellation, the total share capital will decrease from 317,952,508 shares to 316,492,922 shares, and the registered capital will reduce from 318 million yuan to 316 million yuan [1] - The company completed its initial share repurchase from 2022 to 2023, utilizing funds amounting to 99.6937 million yuan [1]